CORTEX PHARMACEUTICALS INC/DE/ 4
4 · CORTEX PHARMACEUTICALS INC/DE/ · Filed Jun 2, 2008
Insider Transaction Report
Form 4
Johnson Steven Andrew
VP, Preclinical Development
Transactions
- Award
Common Stock
[F1]2008-05-30$0.78/sh+11,012$8,589→ 22,012 total
Holdings
- 2,350(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Represents the issuance of common stock in exchange for the cancellation of accrued paid time off in excess of fifty (50) days as of the end of May 2008, based on the officer's current rate of compensation per day and the closing price per share of the Company's common stock on May 30, 2008.
Signature
Maria S. Messinger, Attorney in fact|2008-05-30